James Investment Research’s Sabra Healthcare REIT SBRA Stock Holding History

James Investment Research’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$469K	Hold	24,042	–	–	0.05%	272
2026 Q1	$462K	Buy	24,042 +29	+0.1%	+$571	0.05%	263
2025 Q4	$455K	Hold	24,013	–	–	0.05%	263
2025 Q3	$448K	Buy	24,013 +4,237	+21%	+$79.1K	0.05%	258
2025 Q2	$365K	Hold	19,776	–	–	0.04%	251
2025 Q1	$345K	Hold	19,776	–	–	0.04%	246
2024 Q4	$343K	Hold	19,776	–	–	0.04%	256
2024 Q3	$368K	Buy	19,776 +9,711	+96%	+$164K	0.04%	252
2024 Q2	$155K	Sell	10,065 -2	-0%	-$29	0.02%	298
2024 Q1	$149K	Buy	10,067 +7	+0.1%	+$97	0.02%	299
2023 Q4	$144K	Hold	10,060	–	–	0.02%	285
2023 Q3	$140K	Hold	10,060	–	–	0.02%	266
2023 Q2	$118K	Hold	10,060	–	–	0.02%	265
2023 Q1	$116K	Hold	10,060	–	–	0.02%	291
2022 Q4	$125K	Hold	10,060	–	–	0.02%	287
2022 Q3	$132K	Hold	10,060	–	–	0.02%	293
2022 Q2	$141K	Buy	10,060 +34	+0.3%	+$455	0.02%	281
2022 Q1	$149K	Buy	10,026 +26	+0.3%	+$356	0.02%	296
2021 Q4	$135K	Hold	10,000	–	–	0.01%	309
2021 Q3	$147K	Buy	+10,000	New	+$169K	0.01%	304

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

James Investment Research's SBRA Position: Q2 2026 in Review

James Investment Research held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 24,042 shares worth $469K. The position accounts for 0.05% of the portfolio, ranked #272.

James Investment Research first reported a position in SBRA in Q3 2021 and has held it in 20 quarters since. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

James Investment Research held 24,042 shares of Sabra Healthcare REIT worth $469K as of Q2 2026.
James Investment Research left its Sabra Healthcare REIT share count unchanged in Q2 2026.
Sabra Healthcare REIT made up 0.05% of James Investment Research's portfolio in Q2 2026, its #272 holding.
James Investment Research first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 20 quarters since.
463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.